New antiepileptic drugs

Journal of Head Trauma Rehabilitation

Volumn 11, Issue 4, 1996, Pages 100-103

  Agosti, Reto M ^a,b   Katz, Douglas I ^a,b  

^a Braintree Rehabilitation Hospital   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; TIAGABINE; TOPIRAMATE; VIGABATRIN;

ANOREXIA; APLASTIC ANEMIA; ATAXIA; DIPLOPIA; EPILEPSY; FATIGUE; HEADACHE; HUMAN; INSOMNIA; LIVER FAILURE; NAUSEA; NYSTAGMUS; RASH; SHORT SURVEY; SOMNOLENCE; VERTIGO; VISUAL IMPAIRMENT; VOMITING;

EID: 0029783805     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-199608000-00016     Document Type: Short Survey

References (11)

1. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med. 1996;334:168-175.
2. Dikmen SS, Temkin NR, Miller B, Machamer J, Winn R. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA. 1991;265:1271- 1277.
3. Wolf P. New antiepileptic drugs already registered. Epilepsia. 1994;34:S22-24.
4. Leppik IE. Antiepileptic drugs in development: Prospects for the near nature. Epilepsia. 1994;35:S29-40.
5. Harden CL. New antiepileptic drugs. Neurology. 1994;44:787-795.
6. Tylor CP. Mechanism of action of new antiepileptic drugs. In: Chadwick D, ed. New Trends in Epilepsy Management: The Role of Gabapentin. London, England: Royal Society of Medicine Services; 1993.
7. Mattson RH. Managing epilepsy: The role of gabapentin. Neurology. 1994;44:S1-32.
8. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, crossover trial. Epilepsia. 1994;35:113-121.
9. Pellock JM. The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology. 1994;44:29-35.
10. Bebin M, Bleck TP. New anticonvulsant drugs: Focus on flunabizine, fosphenytoin, midazolam, and stiripentol. Drugs. 1994;2:153-171.
11. Leppik IE, Boucher BA, Wilder BJ, et al. Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patients. Neurology. 1990;40:456-460.